期刊文献+

分析厄贝沙坦氢氯噻嗪对原发性高血压的疗效

Analysis of curative effect of irbesartan and hydrochlorothiazide in patients with primary hypertension
下载PDF
导出
摘要 目的:分析厄贝沙坦氢氯噻嗪在原发性高血压患者中的应用价值。方法:选取60例原发性高血压患者,随机分成两组,35例试验组应用厄贝沙坦氢氯噻嗪治疗,25例对照组单纯应用厄贝沙坦治疗,比较临床疗效。结果:试验组21例降压效果显著,12例治疗有效,2例血压改善不明显,治疗效果为无效,对照组治疗效果为显效、有效、无效的例数分别为13例、7例、5例,与对照组相比,试验组的降压效果更佳,差异存在统计意义(94.3%vs80.0%,P<0.05)。结论:厄贝沙坦氢氯噻嗪可改善患者头晕头痛、心悸气短症状,是治疗原发性高血压的有效药物。 Objective:to analyze the application value in patients with irbesartan and hydrochlorothiazide in hypertension.Methods:60 cases of essential hypertension patients, randomly divided into two groups, experimental group of patients with El Bbe Chatain and hydrochlorothiazide in treatment of 35 cases,25 patients in control group only used irbesartan treatment,compared the clinical efficacy.Results:in the experimental group,21 cases of obvious antihypertensive effect,12 cases effective,2 cases of blood pressure was not significantly improved,treatment is invalid,the number of cases of the control group treatment effect is effective,effective,ineffective was 13 cases,7 cases,5 cases,compared with the control group, patients in the experimental group were better antihypertensive effect,the statistical significance of difference(94.3% VS80.0%,P<0.05).Conclusion:irbesartan and hydrochlorothiazide in patients with dizziness headache,palpitation,shortness of breath,is an effective drug for the treatment of primary hypertension, worthy of further promotion.
出处 《中国社区医师(医学专业)》 2014年第7期30-30,32,共2页
关键词 厄贝沙坦 氢氯噻嗪 原发性高血压 临床疗效 Irbesartan Hydrochlorothiazide Essential hypertension The clinical curative effect
  • 相关文献

参考文献5

二级参考文献28

  • 1王宏宇,马志敏,孙淑红,朱天刚,许玉韵,胡大一.肱动脉内-中膜厚度和冠状动脉粥样硬化病变的关系[J].中国医药导刊,2004,6(6):411-413. 被引量:8
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].高血压杂志,2004,12(6):483-486. 被引量:368
  • 3无,龚兰生,许玉韵,张维忠,刘望彭,王新房,王宏宇,张瑞岩,郭远,李运田,马志敏,芦娜,倪永斌,王敏,杨娅,何建国,高旭光,丁康,沈晨阳,陈生龙,史旭波,陶军.中国血管病变早期检测技术应用指南(第一次报告)[J].中国民康医学,2006,18(9):323-331. 被引量:94
  • 4Kullo IJ, Bielak LF, Turner ST, et al. Aortic pulse wave velocity is associated with the presence and quantity of coronary artery cal- cium. a community based study[J]. Hypertension, 2006,47 (2) 174-179.
  • 5Kita T, SuzukiY, Eto T, etal. Long term antihypertensive thera- py with benidipine improves arterial stiffness over blood pressure lowering[J]. Hypertens Res,2005,28(12):959-964.
  • 6Karalliedde J, Smith A, DeAngelis L, et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering[J]. Hypertension,2008,51(6) :1617-1623.
  • 7Shargorodsky M, Leibovitz E, Lubimov L, etal. Prolonged treat- ment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential hyperten- sion[J]. Am J Hypertens,2002,15(12) : 1087-1091.
  • 8陆再英,钟南山.内科学[M]7A.北京:人民卫生出版社,2008:251.
  • 9刘力生,吴兆苏中国高血压防治指南[s]3版.中国高血压防治指南修订委员会,2010.
  • 10Moan A,hoieggen A. Eidd I.metabolic effects of antihypertensive tre&tment with the Angiotensfn ;I receptor antagoist candesartan[G].Seventh European Meeting on HyPertension,2004"-5.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部